# Disease-Modifying Therapy
Keywords: multiple sclerosis, disease-modifying therapy, immunotherapy, immune system, chronic disease, long-term therapy, immunomodulating, immunosuppressive

> This page provides an overview of disease-modifying therapies for multiple sclerosis (MS), explaining their mechanisms, benefits, and application methods to manage the disease progression and reduce its impact.

## Details
- [Managing MS](#): Disease-modifying therapies can influence the long-term progression of MS by modulating or suppressing the immune system, aiming to prevent relapses and slow down disability progression.
- [Impacting Disease Progression](#): Immunotherapies, while not curative, can reduce inflammation in nerve tissue and delay disease advancement through regular application.
- [Choosing the Right Medication](#): Therapy selection depends on individual MS progression, focusing on effectiveness, safety, and patient preferences regarding administration methods.
- [Long-Term Therapy Options](#): Medications are categorized by effectiveness to help tailor treatment based on disease activity, ranging from mild to highly active MS.
- [Administration Methods](#): MS medications vary in form, including injections, infusions, and oral tablets, with differing frequencies from daily doses to annual cycles.
- [Consistency Matters](#): Regular and consistent use of prescribed therapies is critical for achieving optimal treatment outcomes.